YY1 downregulation underlies therapeutic response to molecular targeted agents.
Zhou S, Zang J, Cai MC, Ye K, Liu J, Ma P, Wu J, Dai C, Lu H, Zhang Q, Jiang J, Chu T, Shen Y, Tan L, Zhuang G, Zhao X, Wang L, Zhuang Y, Fu Y.
Zhou S, et al. Among authors: tan l.
Cell Death Dis. 2024 Nov 27;15(11):862. doi: 10.1038/s41419-024-07239-8.
Cell Death Dis. 2024.
PMID: 39604408